biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..

the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..

as for the assumption that fresh is healthiest, it turns out that frozen produce can pack a punch when it comes to nutrition..